Innospec Inc. (NASDAQ:IOSP) Shares Acquired by Hancock Whitney Corp

Hancock Whitney Corp increased its position in shares of Innospec Inc. (NASDAQ:IOSP) by 48.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,153 shares of the specialty chemicals company’s stock after acquiring an additional 1,686 shares during the period. Hancock Whitney Corp’s holdings in Innospec were worth $637,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Norges Bank bought a new position in shares of Innospec in the fourth quarter valued at $25,925,000. UBS Group AG lifted its holdings in shares of Innospec by 204,935.7% during the fourth quarter. UBS Group AG now owns 57,410 shares of the specialty chemicals company’s stock valued at $7,075,000 after purchasing an additional 57,382 shares during the last quarter. Bell & Brown Wealth Advisors LLC acquired a new position in shares of Innospec in the 4th quarter valued at $643,000. TFO Wealth Partners LLC increased its stake in Innospec by 29,800.0% in the 4th quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock worth $37,000 after purchasing an additional 298 shares in the last quarter. Finally, Evoke Wealth LLC acquired a new stake in Innospec during the 4th quarter worth about $3,866,000. 96.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 8th.

Innospec Stock Down 0.1 %

Shares of Innospec stock opened at $111.83 on Tuesday. The stock has a market cap of $2.79 billion, a PE ratio of 18.99 and a beta of 1.08. Innospec Inc. has a 12 month low of $95.69 and a 12 month high of $133.71. The business has a fifty day simple moving average of $115.52 and a 200-day simple moving average of $121.67.

Innospec (NASDAQ:IOSP) last issued its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.02. Innospec had a return on equity of 14.15% and a net margin of 7.90%. The company had revenue of $435.00 million for the quarter, compared to the consensus estimate of $468.73 million. During the same quarter in the prior year, the company earned $1.28 EPS. The firm’s quarterly revenue was down 9.5% on a year-over-year basis. Analysts expect that Innospec Inc. will post 5.95 EPS for the current fiscal year.

Insider Activity at Innospec

In other Innospec news, CFO Ian Cleminson sold 3,398 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $114.74, for a total value of $389,886.52. Following the completion of the sale, the chief financial officer now owns 12,996 shares of the company’s stock, valued at $1,491,161.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.52% of the stock is currently owned by company insiders.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.